Effects of Roflumilast on Lung Inflammation in Mice Exposed to Cigarette Smoke
Author Information
Author(s): Martorana Piero A, Lunghi Benedetta, Lucattelli Monica, De Cunto Giovanna, Beume Rolf, Lungarella Giuseppe
Primary Institution: Department of Physiopathology and Experimental Medicine, University of Siena, Siena, Italy
Hypothesis
Does roflumilast affect the volume density of inflammatory cells in the lungs of mice exposed to cigarette smoke?
Conclusion
Roflumilast at a higher dose significantly reduces the recruitment of inflammatory cells in the lungs of mice exposed to cigarette smoke.
Supporting Evidence
- Chronic smoke exposure increased neutrophil volume density by 97%.
- Roflumilast at 5 mg/kg prevented the increase in neutrophil volume density by 78%.
- Roflumilast at 5 mg/kg suppressed macrophage volume density increase by 82%.
- Dendritic cell volume density increased by 217% after smoke exposure.
- Roflumilast at 1 mg/kg reduced dendritic cell volume density increase by 42%.
Takeaway
This study shows that a drug called roflumilast can help protect mice's lungs from damage caused by cigarette smoke by reducing the number of harmful immune cells.
Methodology
Mice were exposed to cigarette smoke and treated with roflumilast; lung tissue was analyzed for inflammatory cell volume density using immunohistochemistry.
Limitations
The study was conducted on mice, which may not fully replicate human responses.
Participant Demographics
C57 Bl/6J male mice, 2 months old.
Statistical Information
P-Value
< 0.01
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website